Gene therapy stocks surge on Roche-Spark deal
February 25, 2019 at 09:28 AM EST
Shares of gene therapy companies surged in premarket trade Monday, buoyed by the news of Roche Holding AG’s acquisition of Spark Therapeutics Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
